BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33632326)

  • 1. Effect of stem cell treatment on functional recovery of spinocerebellar ataxia: systematic review and meta-analysis.
    Appelt PA; Comella K; de Souza LAPS; Luvizutto GJ
    Cerebellum Ataxias; 2021 Feb; 8(1):8. PubMed ID: 33632326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of umbilical cord mesenchymal stem cell therapy in hereditary spinocerebellar ataxia.
    Jin JL; Liu Z; Lu ZJ; Guan DN; Wang C; Chen ZB; Zhang J; Zhang WY; Wu JY; Xu Y
    Curr Neurovasc Res; 2013 Feb; 10(1):11-20. PubMed ID: 23151076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal Stem Cell Therapy in the Treatment of Neurodegenerative Cerebellar Ataxias: a Systematic Review and Meta-analysis.
    Bhartiya M; Kumar A; Singh RK; Radhakrishnan DM; Rajan R; Srivastava AK
    Cerebellum; 2023 Jun; 22(3):363-369. PubMed ID: 35451803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validity and reliability of the International Cooperative Ataxia Rating Scale (ICARS) and the Scale for the Assessment and Rating of Ataxia (SARA) in multiple sclerosis patients with ataxia.
    Salcı Y; Fil A; Keklicek H; Çetin B; Armutlu K; Dolgun A; Tuncer A; Karabudak R
    Mult Scler Relat Disord; 2017 Nov; 18():135-140. PubMed ID: 29141795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical analysis of the treatment of spinocerebellar ataxia and multiple system atrophy-cerebellar type with umbilical cord mesenchymal stromal cells.
    Dongmei H; Jing L; Mei X; Ling Z; Hongmin Y; Zhidong W; Li D; Zikuan G; Hengxiang W
    Cytotherapy; 2011 Sep; 13(8):913-7. PubMed ID: 21545234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment for speech disorder in Friedreich ataxia and other hereditary ataxia syndromes.
    Vogel AP; Folker J; Poole ML
    Cochrane Database Syst Rev; 2014 Oct; (10):CD008953. PubMed ID: 25348587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Riluzole for the Treatment of Hereditary Ataxias: A Systematic Review.
    Ayala IN; Aziz S; Argudo JM; Yepez M; Camacho M; Ojeda D; Aguirre AS; Oña S; Andrade AF; Vasudhar A; Moncayo JA; Hassen G; Ortiz JF; Tambo W
    Brain Sci; 2022 Aug; 12(8):. PubMed ID: 36009103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functionality and disease severity in spinocerebellar ataxias.
    Cruz GCD; Zonta MB; Munhoz RP; Mello NM; Meira AT; Nunes MCA; Aranha NTG; Camargo CHF; Lopes Neto FDN; Teive HAG
    Arq Neuropsiquiatr; 2022 Feb; 80(2):137-144. PubMed ID: 35352753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gait characteristics and clinical relevance of hereditary spinocerebellar ataxia on deep learning.
    Jin L; Lv W; Han G; Ni L; Sun D; Hu X; Cai H
    Artif Intell Med; 2020 Mar; 103():101794. PubMed ID: 32143799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of the Scale for Assessment and Rating of Ataxia (SARA).
    Yabe I; Matsushima M; Soma H; Basri R; Sasaki H
    J Neurol Sci; 2008 Mar; 266(1-2):164-6. PubMed ID: 17950753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Related factors of ICARS and SARA scores on spinocerebellar ataxia type 3/Machado-Joseph disease.
    Zhou J; Lei L; Liao X; Wang J; Jiang H; Tang B; Shen L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 36(6):498-503. PubMed ID: 21743140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of transcranial magnetic stimulation on cerebellar ataxia: A systematic review and meta-analysis.
    Wang Y; Zhang D; Wang J; Ma J; Lu L; Jin S
    Front Neurol; 2023; 14():1049813. PubMed ID: 36779066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The correlation between magnetic resonance imaging features of the brainstem and cerebellum and clinical features of spinocerebellar ataxia 3/Machado-Joseph disease.
    Liang X; Jiang H; Chen C; Zhou G; Wang J; Zhang S; Lei L; Wang X; Tang B
    Neurol India; 2009; 57(5):578-83. PubMed ID: 19934555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reliability of the Japanese version of the Scale for the Assessment and Rating of Ataxia (SARA)].
    Sato K; Yabe I; Soma H; Yasui K; Ito M; Shimohata T; Onodera O; Nakashima K; Sobue G; Nishizawa M; Sasaki H
    Brain Nerve; 2009 May; 61(5):591-5. PubMed ID: 19514520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurofilament light chain is a promising serum biomarker in spinocerebellar ataxia type 3.
    Li QF; Dong Y; Yang L; Xie JJ; Ma Y; Du YC; Cheng HL; Ni W; Wu ZY
    Mol Neurodegener; 2019 Nov; 14(1):39. PubMed ID: 31684998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of acetyl-DL-leucine on cerebellar ataxia (ALCAT trial): study protocol for a multicenter, multinational, randomized, double-blind, placebo-controlled, crossover phase III trial.
    Feil K; Adrion C; Teufel J; Bösch S; Claassen J; Giordano I; Hengel H; Jacobi H; Klockgether T; Klopstock T; Nachbauer W; Schöls L; Stendel C; Uslar E; van de Warrenburg B; Berger I; Naumann I; Bayer O; Müller HH; Mansmann U; Strupp M
    BMC Neurol; 2017 Jan; 17(1):7. PubMed ID: 28068987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurorehabilitation therapy in spinocerebellar ataxia type 2: A 24-week, rater-blinded, randomized, controlled trial.
    Rodríguez-Díaz JC; Velázquez-Pérez L; Rodríguez Labrada R; Aguilera Rodríguez R; Laffita Pérez D; Canales Ochoa N; Medrano Montero J; Estupiñán Rodríguez A; Osorio Borjas M; Góngora Marrero M; Reynaldo Cejas L; González Zaldivar Y; Almaguer Gotay D
    Mov Disord; 2018 Sep; 33(9):1481-1487. PubMed ID: 30132999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reliability and validity of the Chinese version of the Scale for Assessment and Rating of Ataxia.
    Tan S; Niu HX; Zhao L; Gao Y; Lu JM; Shi CH; Avinash C; Wang RH; Xu YM
    Chin Med J (Engl); 2013; 126(11):2045-8. PubMed ID: 23769555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Spinocerebellar Ataxia With Mesenchymal Stem Cells: A Phase I/IIa Clinical Study.
    Tsai YA; Liu RS; Lirng JF; Yang BH; Chang CH; Wang YC; Wu YS; Ho JH; Lee OK; Soong BW
    Cell Transplant; 2017 Mar; 26(3):503-512. PubMed ID: 28195034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with autosomal dominant spinocerebellar ataxia have more risk of falls, important balance impairment, and decreased ability to function.
    Aizawa CY; Pedroso JL; Braga-Neto P; Callegari MR; Barsottini OG
    Arq Neuropsiquiatr; 2013 Aug; 71(8):508-11. PubMed ID: 23982006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.